Dr. Barry Dworkin

Study shows ten percent of people, mostly men, with severe COVID-19, develop an autoimmune response that attacks interferons (part of the immune system) thereby reducing the host’s ability to defend against the virus.

Medical Mythbusting Commentary for November 16, 2020

Source:
‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die

Reference:
Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Related posts:

  1. Researchers start the trek to figure out the biological mechanism how COVID infections lead to autoimmune disease even after recovery. First clues found that may lead to understanding Long-COVID. More to come. #GoScience #VaccinesWork
  2. Gene discovery opens new avenue to understand what causes asthma
  3. Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
  4. Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works.